Abstract: Psoriatic arthritis occurs in about 30% of patients with psoriasis and is prevalent in an estimated 0.3% to 1.0% of the general population. This article reports on results from the Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis [PALACE4; NCT01307423].
Publication Year: 2014
Publication Date: 2014-12-01
Language: en
Type: article
Indexed In: ['crossref']
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot